Pfizer
New Research Building
St. Louis, MO
330,000 SF
In an effort to bolster their global research operations, Pfizer’s New Research Building (NRB) consolidates previously dispersed St. Louis Global Research & Development (PGRD) colleagues into a single contiguous facility. The four-story, high-tech research building strengthens the division’s capabilities to deliver new medicines to treat cardiovascular disease, pain and inflammation, chronic obstructive pulmonary disease, and respiratory diseases. NRB primarily houses biology labs, support spaces, offices, and conference rooms. To allow for maximum flexibility and adaptability, offices and labs are organized in an open, modular layout.